Citius Oncology, Inc. - Common Stock (NQ:CTOR)
All News about Citius Oncology, Inc. - Common Stock
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Is ‘One to Watch’
August 25, 2026
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
December 04, 2025
Topics
Government
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
December 04, 2025
From BioMedWire
Via GlobeNewswire
Citius Oncology Beats Fiscal Q3 EPS ↗
August 12, 2025
Via The Motley Fool
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
August 06, 2025
Topics
Government